Objective: To determine the effect of vitamin A, zinc or both on plasma lipid peroxides in a healthy elderly population. Design: Double-blind randomized controlled trial supplementation of vitamin A and zinc. Setting: Public home for elderly people, in Rome, Italy. Subjects: A total of 178 residents of a Public home for elderly people were evaluated regarding health and nutritional status. 136 gave a written consensus to participate in the trial and were randomized in four groups of treatment. 118 elderly completed the trial. Interventions: Three months supplementation of the following treatments: (1) vitamin A (800 mg retinol palmitate); (2) zinc (25 mg zinc as sulphate); (3) vitamin A and zinc (800 mg retinol palmitate and 25 mg zinc as sulphate); (4) placebo (starch containing capsules). Main outcome measures: Plasma lipid peroxides (TBA-RS) were measured before and after supplementation. Results: Zinc supplementation was associated with a decrease in plasma lipid peroxides (b 7 0.19; 95% con®dence levels: 70.37, 70.002; p-value 0.05) after adjusting for sex, smoking habits, baseline plasma lipid peroxides and vitamin A plasma levels. Conclusions: Zinc supplementation decreased plasma lipid peroxides while vitamin A had no effect in this elderly population. Adequate zinc intake or supplementation could play an important role in the prevention and/ or modulation of diseases in the elderly people.
Introduction
Free radicals have been implicated in the aetiology of ageing and diseases related to ageing such as cancer atherosclerosis and arthritis (Halliwell and Gutteridge, 1991) . Polyunsaturated fatty acids are particularly susceptible to free-radical-mediated peroxidation leading to disturbances in membrane structure and function. Lipid peroxidation may also adversely affect immune responses (Bendich, 1992) and can be measured by the assay of thiobarbituric acid reactive substances (TBA-RS) in plasma (Holley and Cheeseman, 1993) .
Zinc and vitamin A intake, whose intake is often suboptimal in the elderly (Bogden et al, 1987; Ferro-Luzzi et al, 1988) may function as antioxidants (Bray and Bettger, 1990; D'Aquino et al, 1989) . There has been little in vivo research undertaken to determine whether zinc and vitamin A provide antioxidant protection in elderly.
The aim of the present randomized double blind clinical trial was to evaluate the effect of vitamin A and zinc supplementation on plasma lipid peroxides in an elderly population.
Subjects and methods
Participants were drawn from a home for elderly people in Rome, Italy (Casa di Riposo Roma III). All individuals, largely self-caring, mobile and cognitively intact, were evaluated for the presence of chronic diseases (chronic bronchitis, diabetes, liver, renal or cardiovascular diseases and previous ictus), disability, cognitive function, depression symptoms, nutritional status, and smoking habits. Medical history was obtained by reviewing clinical records and by interviewing medical staff. Disability assessment was carried out by the senior nurse. Assessment of cognitive function, depression symptoms, smoking and nutritional status was conducted by a trained nurse using standardised questionnaires (Royal College of Physicians of London and the British Geriatric Society, 1992) and standard anthropometric techniques (Lohman et al, 1988) .
Randomization and treatment
All residents who agreed to enter the trial were strati®ed by sex and age (three age groups:`79; 79±84; b 84 years) and were randomly allocated to one of four groups: (1) vitamin A (800 mg retinol palmitate per day); (2) zinc (25 mg zinc as sulphate per day); (3) vitamin A and zinc (800 mg retinol palmitate and 25 mg zinc as sulphate per day); (4) placebo (starch containing capsules per day).
Randomization was carried out by computer generated random number allocation.
Capsules were self-administered once a day with the main meal for three consecutive months. Compliance, de®ned as those taking at least 85% of the total supplementation pills that were allocated, was checked by means of tablet counts every 10±15 d.
Blood collection and biochemical analysis Subjects had blood samples collected within a one week period before and after supplementation. Fasting venous blood specimens (25 ml) were collected in EDTA tubes and brought to the laboratory within an hour. Plasma vitamin A was measured by high pressure liquid chromatography according to the method of Bieri and coworkers (Bieri et al, 1979) . Plasma zinc and copper concentration was determined by atomic-absorption spectroscopy (Smith et al, 1979) . Lipid peroxides in plasma were expressed as TBA-RS as described by Bauali and colleagues (Bauali et al, 1994) . The trial protocol followed the ethical requirements for conducting clinical trials established by the European Economic Community (EEC document no. 91/ 507) and the trial protocol was approved by the local Ethics Committee of the Catholic University of Rome.
Data analysis
Based on the intention-to-treat principle, non-compliant subjects (those who did not take at least 85% of the pills) were included in the analysis. The outcome variable of interest was the absolute change of plasma lipid peroxides (TBA-RS). Chi-square test and one-way analysis of variance (ANOVA) were used to evaluate differences in baseline characteristics among the four randomized groups. Paired sample t±test was used to evaluate changes of total cholesterol and plasma copper within zinc group. The distribution of both baseline TBA-RS levels and absolute changes after treatment were tested for normality. The effect of supplementation was analyzed in terms of absolute difference of plasma lipid peroxides (TBA-RS values after treatment minus TBA-RS values before treatment).
The zinc effect was examined by pooling the zinc treated groups and comparing the differences in TBA-RS with the non-zinc treated groups. The effect of vitamin A was evaluated by pooling the vitamin A groups and comparing the differences in TBA-RS levels with the non-vitamin A groups. ANOVA was used to test the effect of vitamin A and zinc supplementation on TBA-RS levels and to test for interaction between the effects of vitamin A and zinc. To control for confounders, multiple linear regression was used, with the change in lipid peroxides as the dependent variable.
Results
A total of 136 subjects gave written consent to participate in this study, and 107 subjects completed the trial. Table 1 shows characteristics of the study participants by treatment group. There were no differences in baseline characteristics of the four treatment groups for sex, age, chronic diseases, smoking habits, cognitive function, disability, body mass index (BMI), baseline plasma levels of vitamin A and zinc. However, a difference in depression score between the four groups was observed (P 0.03).
TBA-RS levels were signi®cantly associated with sex (P 0.01) and baseline vitamin A levels (P 0.02). A non statistically signi®cant difference was also observed for smoking status (P 0.06) (data not shown). Table 2 and Table 3 show baseline and absolute change (mean change from baseline) in plasma lipid peroxides (TBA-RS) in zinc and vitamin A groups, respectively. TBA-RS levels fell in the zinc group but did not reach statistical signi®cance (P 0.09). In strati®ed analyses, the effect of zinc in decreasing TBA-RS was greater for smokers (P 0.03). No differences were found for the vitamin A supplemented group. Table 4 shows the results of the linear regression models. The estimated effect of zinc on TBA-RS was 70.18 (95% con®dence interval (CI) 70.4;0.03) (model 1). When adjustment was made for baseline values of lipid peroxides, a similar effect of zinc supplementation was observed (P 0.07) (model 2). When adjustment was also made for baseline values of lipid peroxides and those variables associated with TBA-RS (sex, smoking status and plasma vitamin A), a statistical signi®cant decrease was observed in the estimated zinc effect of zinc supplementation (b coef®cient 70.19, 95% CI 70.37; 70.002, P 0.05). No statistical difference in the estimated effect of vitamin A supplementation was detected.
The amount of zinc supplementation given in this study had no effect on copper levels (before supplementation m 1.17 (0.24) mg/L; after supplementation m 1.11 (0.19) mg/L P 0.22) and total cholesterol (before supplementation m 225.8 (47.2) mg/dl; after supplementation m 221.5 (46.4) mg/dl P 0.49) within zinc group.
Discussion
Aging is associated with higher formation of free radicals and decreased antioxidant capacities (Nohl, 1993) . Both vitamin A and zinc have an antioxidant role in a range of animals and in vitro models (Bray and Bettger, 1990; D'Aquino et al, 1989; Livrea et al, 1995) . In this study, zinc supplementation was associated with a decrease in lipid peroxides measured by thiobarbituric acid reactive substances (TBA-RS) after adjusting for baseline levels of plasma lipid peroxides and vitamin A, sex and smoking habits. Vitamin A supplementation, however, was not associated with any TBA-RS changes.
The positive effect of zinc on lipid peroxidation may be explained by the protection of zinc on sulphydryl groups against oxidation, and the production of hydroxyl and superoxide ion radicals by transition metal (Bray and Bettger, 1990) . Zinc is also an essential component of superoxide dismutase (SOD), a free radical scavenger enzyme (Willson, 1988) . In a study in which ®ve male runners were supplemented with 25 mg of zinc, zinc lowered free radical production due to exercise and enhanced respiratory burst activity of isolated neutrophils (Singh et al, 1994) . In contrast to our ®ndings, 50 mg of zinc given daily for four weeks to 10 healthy volunteers did not decrease lipid oxidation (Gatto and Samman, 1995) ; however, the amount of zinc given might have been too high. High zinc supplementation may inhibit SOD activity (Samman, 1993; Bettger, 1993) .
A single oral dose with 20 000 IU of vitamin A has been reported to increase the resistance of low density lipoprotein (LDL) to peroxidation (Livrea et al, 1995) . In our study vitamin A had no effect on lipid peroxidation. It is possible that a small daily dose of vitamin A (4 000 IU) as given in our study is not effective on protecting biological mem- Zinc supplementation and plasma lipid peroxides C Fortes et al branes against lipid peroxidation measured by TBA-RS method. Furthermore, the method we used to assess lipid peroxidation (TBA-RS) in our study is not speci®c for LDL. It is possible that vitamin A supplementation is only effective against peroxidation of linoleic acid, the main component of LDL.
The effect of zinc supplementation on lipid peroxides observed in our study was also accompanied by a signi®-cant increase in some T-cell subsets (Fortes et al, 1995) , suggesting that the antioxidant effect of zinc may have affected directly T-cell proliferation. It has been suggested that the decreased lymphocyte proliferation observed in ageing may be due to the impaired activation of protein kinase C. Impaired activation of protein kinase C, could be attributed to changes in membrane¯uidity caused by increased lipid peroxidation (Eze, 1992) .
The present trial achieved high levels of compliance among a relatively healthy population who could be kept under close supervision because they live in an institution. The duration of the trial was short, but the problems of maintaining high compliance over a longer time period, and the possibility of confounding due to external factors, such as dietary change, precluded a longer trial. Control of dietary intake was assured which means that the signi®cant fall in TBA-RS observed in subjects receiving zinc supplementation re¯ects a real decrease of lipid peroxides and not a change in dietary pro®le (Benzie, 1996) . Zinc supplementation might interfere in copper and cholesterol metabolism (Sandstead, 1995) . Total cholesterol and plasma copper levels did not change after zinc supplementation in this study, suggesting that zinc dose was not high enough to interfere on copper and cholesterol levels.
Conclusions
We have observed a positive effect of zinc on plasma lipid peroxides in an elderly population. In addition, zinc appears to have bene®cial effects on immunological indicators. Further work is required to examine the cellular mechanisms by which zinc lowers plasma lipid peroxides and affects cell-mediated immunity. Adequate zinc intake or supplementation could play an important role in the prevention and/or modulation of diseases in the elderly people.
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